Will Pfizer Be a Trillion-Dollar Stock by 2035?

Some investors look at Pfizer (PFE -1.08%) as a has-been. That's understandable in some ways. Sales for the company's once-formidable COVID-19 franchise have tanked. So have Pfizer's overall revenue, profits, and share price.However, there's an argument that Pfizer is more of a "will-be" than a has-been. Could the drugmaker even be a trillion-dollar stock by 2035?How it could happenThe math is straightforward for how Pfizer could reach a market cap of $1 trillion over the next 11 or so years. Pfizer's marke ...